Rabbit Polyclonal APC11 antibody. Suitable for WB and reacts with Human samples. Cited in 3 publications. Immunogen corresponding to Synthetic Peptide within Human ANAPC11 aa 1-100.
View Alternative Names
HSPC214, ANAPC11, Anaphase-promoting complex subunit 11, APC11, Cyclosome subunit 11, Hepatocellular carcinoma-associated RING finger protein
- WB
Unknown
Western blot - Anti-Apc11 antibody (AB154546)
15% SDS PAGE
All lanes:
Western blot - Anti-Apc11 antibody (ab154546) at 1/5000 dilution
Lane 1:
H1299 whole cell lysate at 30 µg
Lane 2:
MOLT4 whole cell lysate at 30 µg
Predicted band size: 9 kDa
false
Reactivity data
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The small protein is an integral part of the APC/C facilitating the ubiquitination of specific substrates that target them for proteasomal degradation. This process is important for the transition from metaphase to anaphase during mitosis. As part of the APC/C complex Apc11 works closely with other subunits like Apc2 which together enable ubiquitin chain assembly on target proteins. This post-translational modification triggers degradation mechanisms that ensure proper cell cycle progression.
Pathways
Apc11 holds an important position in the cell cycle pathway and the ubiquitin-proteasome degradation pathway. These pathways are essential for maintaining genomic stability by controlling the degradation of regulatory proteins. Apc11 connects with other cycle-regulating proteins such as Cyclin B and Securin both of which are marked for degradation by the APC/C complex. These interactions highlight Apc11’s role in governing the precise timing of cell division events.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (3)
Recent publications for all applications. Explore the full list and refine your search
Experimental & molecular medicine 55:1232-1246 PubMed37258580
2023
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 13:7732 PubMed36513638
2022
Applications
Unspecified application
Species
Unspecified reactive species
British journal of pharmacology 178:280-297 PubMed32986862
2020
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com